l carnitine peyronies disease PEYRONIE'S DISEASE: A REVIEW OF ETIOLOGY, DIAGNOSIS, AND MANAGEMENT Peyronie's Disease Overview, Symptoms, Diagnosis
Description
Aug 2018;6(8):605-617
B Cell in Autoimmune Diseases Scientifica (Cairo) 2012 2012 PMC3692299 Cummings, DE
Flores, B
Stereologic methods and their application in kidney research
L'invention concerne galement l'utilisation de la L-lysine pour potentialiser l'effet de la L-carnitine dans la prparation d'un mdicament destin au traitement des perturbations musculaires lies une hypoexcitabilit ou une hypocontractilit.The invention also relates to the use of L-lysine to potentiate the effect of L-carnitine in the preparation of a medicament intended for the treatment of muscular disturbances linked to hypoexcitability or hypocontractility
